Search results
Gateway - Quartz
Quartz· 3 days agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both ...
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 3 days agoIt’s not surprising that Sanders, one of the most vociferous critics of the pharmaceutical industry in Congress, would take such a critical approach.
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
Reuters via Yahoo News· 7 days agoA U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to...
Why the GLP-1 impact on other industries 'will take years'
Yahoo Finance via AOL· 3 days agoThat represents 7% of the projected US population. In this scenario, insurance coverage is about as...
A warning about 'knock-off' weight loss drugs: HealthLink
KING5 Seattle· 7 days agoWegovy is currently under the U.S. Food and Drug Administration's list of drug shortages as demand...
Eli Lilly Has a New Drug That Could Push the Stock Higher
Motley Fool via Yahoo Finance· 22 hours agoMedicare coverage Another reason to feel upbeat about the future of donanemab is that Medicare has...
India's gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs...
Fortune· 2 days agoSuch is the interest that the anti-obesity medication market could reach $100 billion by 2030, Goldman Sachs Research said. Indians, meanwhile, have simply been watching this from the sidelines ...
Gateway - Quartz
Quartz· 3 days agoJohnson & Johnson agreed this week to settle a multi-state case alleging it misled consumers about the safety of its talc-based powder products. Moderna said its experimental COVID-flu combo ...
Bernie Sanders will grill Novo Nordisk's CEO over Ozempic and Wegovy prices
Quartz· 4 days agoCEO Lars Fruergaard Jørgensen will testify before the Senate's health committee after Sanders...
Gateway - Quartz
Quartz· 4 days agoIn response, the Danish Medicines Agency announced on Wednesday that it has decided to cut some subsidies for the drug, most known for its weight loss side ...
